New drug combo tested as last hope for tough lung cancers
NCT ID NCT01737502
Summary
This study tested a combination of two oral drugs, auranofin and sirolimus, for patients with advanced or returning lung cancer who had run out of standard treatment options. The main goals were to find the safest dose and see if the treatment could slow the cancer's growth. The trial involved 29 patients and was designed to measure how long patients lived without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
Conditions
Explore the condition pages connected to this study.